UK markets open in 1 hour 8 minutes

MDxHealth SA (MDXH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.4900+0.0400 (+1.63%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 67.95M
Enterprise value 75.97M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.89
Price/book (mrq)3.81
Enterprise value/revenue 1.19
Enterprise value/EBITDA -2.90

Trading information

Stock price history

Beta (5Y monthly) -379,815.16
52-week change 3-34.65%
S&P500 52-week change 322.64%
52-week high 34.6400
52-week low 30.3500
50-day moving average 32.9112
200-day moving average 33.1838

Share statistics

Avg vol (3-month) 375.91k
Avg vol (10-day) 345.29k
Shares outstanding 527.29M
Implied shares outstanding 628.12M
Float 817M
% held by insiders 12.63%
% held by institutions 140.30%
Shares short (15 Apr 2024) 464.97k
Short ratio (15 Apr 2024) 40.72
Short % of float (15 Apr 2024) 40.35%
Short % of shares outstanding (15 Apr 2024) 40.24%
Shares short (prior month 15 Mar 2024) 423.35k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -61.40%
Operating margin (ttm)-32.51%

Management effectiveness

Return on assets (ttm)-13.76%
Return on equity (ttm)-521.70%

Income statement

Revenue (ttm)70.19M
Revenue per share (ttm)2.70
Quarterly revenue growth (yoy)50.50%
Gross profit (ttm)N/A
EBITDA -20.47M
Net income avi to common (ttm)-43.1M
Diluted EPS (ttm)-2.1000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)22.38M
Total cash per share (mrq)0.81
Total debt (mrq)41.27M
Total debt/equity (mrq)572.49%
Current ratio (mrq)1.96
Book value per share (mrq)0.26

Cash flow statement

Operating cash flow (ttm)-21.5M
Levered free cash flow (ttm)-20.07M